Video

Dr. Lilenbaum on the Challenges of Integrating Telehealth Services in Lung Cancer

Rogerio C. Lilenbaum, MD, discusses the challenges of integrating telehealth services in lung cancer.

Rogerio C. Lilenbaum, MD, director, Banner MD Anderson Cancer Center, discusses the challenges of integrating telehealth services in lung cancer.

In the era of the coronavirus disease 2019 (COVID-19), telehealth has become a key tool in the continuum of patient care. However, despite best efforts to streamline virtual care before the COVID-19 pandemic, challenges remain in utilizing telehealth to its full potential, says Lilenbaum.

Although many of these hurdles have been overcome over the course of the pandemic, it is not fully understood what role telemedicine will play in cancer care after the pandemic, concludes Lilenbaum.

Related Videos
Suresh Senan, MRCP, FRCR, PhD, full professor, treatment and quality of life, full professor, cancer biology and immunology, full professor, radiation oncology, professor, clinical experimental radiotherapy, Amsterdam University Medical Centers
Alison Schram, MD
Mary B. Beasley, MD, discusses molecular testing challenges in non–small cell lung cancer and pancreatic cancer.
Mary B. Beasley, MD, discusses the multidisciplinary management of NRG1 fusion–positive non–small cell lung cancer and pancreatic cancer.
Mary B. Beasley, MD, discusses the role of pathologists in molecular testing in non–small cell lung cancer and pancreatic cancer.
Mary B. Beasley, MD, discusses the role of RNA and other testing considerations for detecting NRG1 and other fusions in solid tumors.
Mary B. Beasley, MD, discusses the prevalence of NRG1 fusions in non–small cell lung cancer and pancreatic cancer.
Priya U. Kumthekar, MD
David Schiff, MD
Timothy Gershon, MD, PhD